Sequencing reagents and flow cells
ID: 80NSSC24881103QType: Special Notice
Overview

Buyer

NATIONAL AERONAUTICS AND SPACE ADMINISTRATIONNATIONAL AERONAUTICS AND SPACE ADMINISTRATIONNASA SHARED SERVICES CENTERSTENNIS SPACE CENTER, MS, 39529, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/e0d211ededbe40d38ec08388d84ee51b/view
Timeline
    Description

    NASA's National Aeronautics and Space Administration (NASA) is seeking to procure sequencing reagents and flow cells, which are critical for RNA sequencing from various tissues collected during space missions. This procurement is part of the NASA GeneLab project, aimed at expanding the volume and utility of omics data from spaceflight experiments, and the reagents must be compatible with the Illumina NovaSeq 6000 platform to ensure effective library preparation and sequencing. The selected contractor will deliver the required reagents to the NASA Ames Research Center within 15 days post-contract award, with options for partial deliveries, emphasizing NASA's commitment to advancing biological research. Interested organizations must submit their capabilities and qualifications in writing to Sara Jusino-Terry at sara.a.jusino-terry@nasa.gov by 12 p.m. Central Standard Time on September 9, 2024, to be considered for this sole source contract with Illumina, Inc.

    Point(s) of Contact
    Sara Jusino-Terry
    sara.a.jusino-terry@nasa.gov
    Files
    Title
    Posted
    SATPC0036434 Tab 04 4 SOW.pdf
    The NASA GeneLab project, part of its Biological and Physical Sciences initiative, aims to expand the volume and utility of omics data from spaceflight experiments. To achieve this, GeneLab maintains an open-access repository and generates additional omics data from previously unused materials. This specific Request for Proposal (RFP) focuses on procuring sequencing reagents necessary for RNA sequencing from various tissues collected during space missions. The required reagents must be capable of preparing libraries from total RNA and DNA, generating substantial sequencing clusters, and being compatible with the Illumina NovaSeq 6000 platform. The selected contractor will deliver these reagents to the NASA Ames Research Center, adhering to a timeline of 15 days post-contract award or as stipulated by GeneLab, with options for partial deliveries. This effort underscores NASA's commitment to advancing biological research and ensuring the maximal use of spaceflight data for scientific exploration.
    Lifecycle
    Title
    Type
    Sequencing reagents and flow cells
    Currently viewing
    Special Notice
    Similar Opportunities
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    QuantStudio 7 Pro Real-Time PCR System Hardware Maintenance
    Active
    National Aeronautics And Space Administration
    NASA's National Aeronautics and Space Administration (NASA) is seeking proposals for the maintenance of a QuantStudio 7 Pro Real-Time PCR System, which is critical for operations at the Johnson Space Center in Houston, Texas. The procurement includes not only the hardware itself but also a comprehensive Maintenance Agreement to ensure its operational readiness from October 24, 2024, to October 23, 2025, with an immediate delivery request. This initiative underscores NASA's commitment to maintaining cutting-edge technology for its mission-critical laboratory work. Interested small businesses must submit their proposals by November 7, 2024, and direct any inquiries to Cara Craft at cara.s.craft@nasa.gov.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for the procurement of Illumina Reagents and Consumables. This opportunity falls under the NAICS code 334516, which pertains to Analytical Laboratory Instrument Manufacturing, and is classified under the PSC code 6505 for Drugs and Biologicals. The reagents and consumables are critical for various biomedical research applications, supporting the NIH's mission to advance health and medical knowledge. Interested vendors should reach out to Ethan Mueller at ethan.mueller@nih.gov for further details regarding this sources sought notice.
    SOURCES SOUGHT: Long read sequencing services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide long read sequencing services as part of the Global Parkinson’s Genetics Program (GP2). The objective is to genotype over 150,000 individuals worldwide to enhance understanding of genetic risk factors associated with Parkinson’s Disease, requiring the contractor to perform long read sequencing on 500 human genomic DNA samples with a minimum coverage of 25X per sample, alongside ancillary services such as DNA fragmentation, library preparation, and bioinformatics support. Interested parties must submit their capability statements by November 15, 2024, at 9:00 AM Eastern Time, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring compliance with the specified guidelines and format.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    A--Next Generation Sequencing (NGS) Services
    Active
    Environmental Protection Agency
    The Environmental Protection Agency (EPA) is seeking proposals for Next Generation Sequencing (NGS) services to support its gene expression translational research initiatives. The objective of this procurement is to transition from traditional microarray and quantitative polymerase chain reaction technologies to more advanced and cost-effective sequencing-based studies, which are essential for fulfilling various research program obligations. This opportunity is significant as it reflects the EPA's commitment to utilizing cutting-edge technology to enhance its research capabilities. The anticipated solicitation release date is mid to late November, with proposals due approximately 30 days thereafter. Interested parties should contact Zachary Reynolds at reynolds.zachary@epa.gov or (513) 569-7416 for further information.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    Engineering Fluid for Oxygen Cleaning
    Active
    National Aeronautics And Space Administration
    The National Aeronautics and Space Administration (NASA) is seeking bids for the procurement of 594 pounds of 3M's Novec 7100 Engineered Fluid, which is essential for oxygen cleaning processes at NASA Glenn Research Center. This procurement is a Brand Name requirement, limited to authorized resellers of 3M, due to the fluid's unique approval for onsite cleaning, which is critical for maintaining stringent cleaning standards in various projects, including fuel cell and cryogenic testing. The contract is set to be awarded by October 16, 2024, with a total estimated cost extending until December 31, 2024, and interested vendors must provide their Unique Entity Identifier (UEI) and delivery lead time in their quotes. For further inquiries, potential offerors can contact Jacqueline Townley at jacqueline.e.townley@nasa.gov or Karen Artis at Karen.L.Artis@nasa.gov.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    TECHNOLOGY TRANSFER OPPORTUNITY: Portable Science Enclosure Features Unique Innovations (MSC-TOPS-126)
    Active
    National Aeronautics And Space Administration
    Special Notice NATIONAL AERONAUTICS AND SPACE ADMINISTRATION is seeking inquiries from companies interested in obtaining license rights to commercialize, manufacture, and market a portable science enclosure system for science experiments conducted aboard the International Space Station (ISS). This technology allows users to safely manipulate objects of study within a transparent enclosure and can support experiments requiring Biosafety Level 2 containment. The enclosure features innovative protective boundary layer designs that may be transferable to other containment systems. It has a compact, low-profile, rectangular design that is easily stowed and transported. The enclosure system, glove seal, and through-port are available for patent licensing. Interested parties can submit a license application through NASA's Automated Technology Licensing Application System (ATLAS). For more information, visit the NASA Technology Transfer Portal. No follow-on procurement is expected from this notice.